Pure Global

BYO COLOMBIA SAS - Authorized Company ProfileBYO COLOMBIA SAS

Explore comprehensive authorized company profile for BYO COLOMBIA SAS through Pure Global AI's free Colombia medical device database. This company manufactures 101 medical devices registered with INVIMA across 4 risk classes. Their registration history spans from Feb 08, 2022 to Jan 03, 2031.

This page provides detailed insights including recent registrations, risk class distribution (III: 12, II: 80, Unspecified: 6, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
101 Devices
4 Risk Classes
BYO COLOMBIA SAS
BYO COLOMBIA SAS
Authorized Company
101
Total Devices
4
Risk Classes
2022
Earliest
2031
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

EUROLINE COELIAC DISEASE PROFILE (IGA)

EUROLINE COELIAC DISEASE PROFILE (IGA)

10e63bae66e9fa2d1e75f8915d3031ce

II
Jan 03, 2031

EUROLINE AUTOIMMUNE INFLAMMTORY MYOPATHIES 16 AG (IGG)

EUROLINE AUTOIMMUNE INFLAMMTORY MYOPATHIES 16 AG (IGG)

ba42926539336442a79cf5ad3e53009b

II
Jan 03, 2031

ANTI-ACETYLCHOLINE RECEPTOR ELISA (IGG)

ANTI-ACETYLCHOLINE RECEPTOR ELISA (IGG)

b6e2e1dc60bcf04af624bd4cb917cfde

II
Jan 03, 2031

EUROLINE AUTOIMMUNE INFLAMMTORY MYOPATHIES 16 AG ET CN-1A (IGG)

EUROLINE AUTOIMMUNE INFLAMMTORY MYOPATHIES 16 AG ET CN-1A (IGG)

49e3b1150fa1fb9633b21e72231dcade

II
Jan 03, 2031

EUROLINE ANTI-GANGLIOSIDES PROFILE 1 (IGG)

EUROLINE ANTI-GANGLIOSIDES PROFILE 1 (IGG)

0ac04d01d266887082b0aa6b700cc3b5

II
Jan 03, 2031

EUROLINE ANTI-GANGLIOSIDES PROFILE 1 (IGM)

EUROLINE ANTI-GANGLIOSIDES PROFILE 1 (IGM)

f501f07be31ddd873becfa1c5294db87

II
Jan 03, 2031

EUROLINE COELIAC DISEASE PROFILE (IGG)

EUROLINE COELIAC DISEASE PROFILE (IGG)

60df07dbf892e9c5c91f3311ffb2cbd8

II
Jan 03, 2031

ANTI-GAD ELISA (IGG)

ANTI-GAD ELISA (IGG)

59c1cd236efe7c8fe5f54d30bf152544

II
Jan 03, 2031

ANTI-EBNA-1 ELISA (IGG)

ANTI-EBNA-1 ELISA (IGG)

7b9f76661d921b3f0e868ec5d1021b76

Dec 15, 2030

ANTI-MYCOPLASMA PNEUMONIAE ELISA (IGG)

ANTI-MYCOPLASMA PNEUMONIAE ELISA (IGG)

69f69ff41f49ba5215761c2302226b0b

Dec 15, 2030

EUROLINE ANTI-GANGLIOSIDES PROFILE 2 (IGG)

EUROLINE ANTI-GANGLIOSIDES PROFILE 2 (IGG)

b1faecf41ecdfb2be2d2f6d97bbbaa52

Dec 15, 2030

ANTI-MYCOPLASMA PNEUMONIAE ELISA (IGM)

ANTI-MYCOPLASMA PNEUMONIAE ELISA (IGM)

52c7ef3c8986daaef4a7aa896d789aee

Dec 15, 2030

ASPERGILLUS ANTIGEN ELISA

ASPERGILLUS ANTIGEN ELISA

a65b3ab1076297b7980cf83cfc6977b3

Dec 15, 2030

IIFT: GRANULOCYTE (HCHO) EUROPATTERN

IIFT: GRANULOCYTE (HCHO) EUROPATTERN

5a9a29ac1644ee6f46e1b417461a5aee

II
Dec 15, 2030

EUROLINE ANTI-GANGLIOSIDES PROFILE 2 (IGM)

EUROLINE ANTI-GANGLIOSIDES PROFILE 2 (IGM)

4047a8de2808d66f1978dd11da48294b

Dec 15, 2030

2-CAT ELISA

2-CAT ELISA

8cce521f814d23169f64a2463e97e265

II
Nov 27, 2030

ESTRIOL UNCONJUGATED ELISA

ESTRIOL UNCONJUGATED ELISA

0f9b7dec791dd99969121a6681978480

II
Nov 27, 2030

ESTRIOL TOTAL ELISA

ESTRIOL TOTAL ELISA

90eaa727ab8960bc6d7023da516e77ac

II
Nov 27, 2030

CORTISOL IN URINE ELISA

CORTISOL IN URINE ELISA

2c46cb51d0b7c5b0179c5ea5bb000d3e

II
Nov 27, 2030

5-HIAA ELISA

5-HIAA ELISA

8e57b9238fb583151948c23dc69e98d9

II
Nov 27, 2030
Risk Class Distribution
Devices by risk class
II
80
79.2% of total
III
12
11.9% of total
Unspecified
6
5.9% of total
IIa
3
3.0% of total